NanoViricides
NNVC
#10132
Rank
A$33.5 M
Marketcap
A$1.86
Share price
0.82%
Change (1 day)
-17.75%
Change (1 year)

NanoViricides (NNVC) - Cash on Hand

Cash on Hand as of June 2025 : A$2.35 Million

According to NanoViricides's latest financial reports the company has A$2.35 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NanoViricides - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30A$7.18 M-41.22%
2023-06-30A$12.22 M-40.03%
2022-06-30A$20.39 M-25.47%
2021-06-30A$27.36 M37.77%
2020-06-30A$19.86 M445.93%
2019-06-30A$3.63 M-61.97%
2018-06-30A$9.56 M-51.36%
2017-06-30A$19.66 M-39.37%
2016-06-30A$32.43 M-20.69%
2015-06-30A$40.89 M5.09%
2014-06-30A$38.91 M155.17%
2013-06-30A$15.25 M9.43%
2012-06-30A$13.93 M61.95%
2011-06-30A$8.6 M4.8%
2010-06-30A$8.21 M293.23%
2009-06-30A$2.08 M144.65%
2008-06-30A$0.85 M-25.32%
2007-06-30A$1.14 M-66.28%
2006-06-30A$3.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
BioCryst Pharmaceuticals
BCRX
A$0.32 B 13,558.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.15 B 48,848.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$11.12 B 471,425.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$24.97 B 1,058,697.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$27.57 B 1,168,542.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$6.72 B 285,059.38%๐Ÿ‡ฌ๐Ÿ‡ง UK